Please login to the form below
Amjevita
This page shows the latest Amjevita news and features for those working in and with pharma, biotech and healthcare.
Settlement clears path for Biogen, Samsung’s Humira biosimilar
Amgen’s agreement was slightly different in that US sales of its Amjevita biosimilar can start from January 31, and both deals include royalty payments to AbbVie, although the details of
Latest news
-
Novartis joins biosimilar Humira push in US
Pharma giant hopes its candidate will follow in the footsteps of Amgen’s Amjevita and BI’s Cyltezo. ... The biosimilar is vying to be the third copycat version of AbbVie’s Humira (adalimumab) in the big US market after Amgen’s Amjevita and
-
AbbVie deal with Amgen sets biosimilar Humira launch dates
Amgen secured approval in Europe for its biosimilar under the Amgevita brand name in March and in the US as Amjevita a year ago, said that the drug will be one
-
Sandoz says Humira biosimilar clears clinical hurdle
the go-ahead for its product - known as Amjevita in the US market - in September 2016.
-
New EU and US approvals for Humira biosimilars
It is the second to claim marketing approval in the US market after Amgen's Amjevita (adalimumab-atto), which got the go-ahead in September 2016. ... AbbVie is claiming patent protection for Humira in the US out to 2022 and has already taken legal action
-
Amgen wins European approval for Humira biosimilar Amgevita
Amgen’s Humira biosimilar was approved last September in the US under the brand name Amjevita (adalimumab-atto), whose non-proprietary name follows January biosimilar guidance from the FDA for the
More from news
Approximately 2 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Roche’s Ocrevus boasts positive long-term data in MS
- Leadership change within Bedrock Group
- Lilly starts large-scale trial of tirzepatide in diabetic heart disease
- Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
- AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
PMHub
Frontera Group
Welcome to Frontera Group, where our agencies immerse you in the world of the patient...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
